Our advanced disposable autoinjector platform provides a safe, reliable solution for subcutaneous drug delivery, specifically optimized for weight loss treatments and diabetes management. The device incorporates multiple safety features including permanently hidden needles and passive locking needle covers to prevent needlestick injuries.
The autoinjector operates through a simple 2-step process: needle cover activation followed by push-on-skin release. Users receive clear confirmation through audible clicks, visual indicators, and tactile feedback throughout the injection process. The ultra-compact design allows for convenient one-handed operation.
Compatible with both glass and polymer prefilled syringes from major manufacturers, our autoinjectors support various therapeutic applications including GLP-1 peptide treatments (Wegovy® similar), Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide/">Tirzepatide® (Mounjaro®), and Dulaglutide® (Trulicity®). The platform accommodates different viscosities (≤20cP) and offers customizable injection time parameters.
Key technical specifications include standardized 27G/29GTW needle diameters (or smaller), consistent 6±2mm injection depth, and compact exterior dimensions (18×18×145mm/159.2mm). The injection mechanism ensures complete delivery of fixed doses with visual and auditory confirmation upon completion.
Manufactured with medical-grade plastic materials, these autoinjectors are available in multiple configurations (1ml and 2.25ml capacities) to meet various project requirements. The ergonomic housing design can be customized with different surface textures and colors while maintaining functional integrity.